Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using SIRT2 mAb against human SIRT2 (AA: 275-389) recombinant protein. (Expected MW is 38.3 kDa)Application
Figure 3:Western blot analysis using SIRT2 mAb against HEK293 (1) and SIRT2 (AA: 275-389)-hIgGFc transfected HEK293 (2) cell lysate.| Product Name | SIRT2 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SIR2; SIR2L; SIR2L2 |
| Immunogen | Purified recombinant fragment of human SIRT2 (AA: 275-389) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBICC/IF |
| WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | SIR2 SIR2L SIR2L2 |
|---|---|
| Molecular Weight(MW) | 43.2kDa |
| Entrez Gene | 22933 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using SIRT2 mAb against human SIRT2 (AA: 275-389) recombinant protein. (Expected MW is 38.3 kDa)
Application
Figure 3:Western blot analysis using SIRT2 mAb against HEK293 (1) and SIRT2 (AA: 275-389)-hIgGFc transfected HEK293 (2) cell lysate.| Application Notes | WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
